Study to Evaluate Use of Albuterol Multidose Dry Powder Inhaler With an eModule in Participants With Asthma
- Study Title
- A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma
- Teva Identifier
- ABS-AS-30064
- ClinicalTrials.gov Identifier
- NCT02969408
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol Sulfate
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- February 13, 2017 - February 2, 2018
- Phase
- Phase 3
